Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 4, 2010, Pages 449-456

  Paterson, Neil E ^a   Fedolak, Allison ^a   Olivier, Berend ^a,b   Hanania, Taleen ^a   Ghavami, Afshin ^a   Caldarone, Barbara ^a  

^a PSYCHOGENICS INC   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bupropion; Caffeine; Citalopram; Cocaine; D amphetamine; Desipramine; Drug discrimination; GBR12909; Locomotor sensitization; Modafinil; Mouse; Rat

Indexed keywords

AMFEBUTAMONE; CAFFEINE; CITALOPRAM; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; MODAFINIL; MORPHINE; NICOTINE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; WITHDRAWAL SYNDROME;

ANIMALS; BENZHYDRYL COMPOUNDS; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROTRANSMITTER UPTAKE INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; WAKEFULNESS;

MUS; RATTUS; RODENTIA;

EID: 77952551429     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.03.006     Document Type: Article

References (64)

1. Baker L.E., Riddle E.E., Saunders R.B., Appel J.B. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 1993, 4:69-79.
2. Baldo B.A., Kelley A.E. Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor. Brain Res Bull 1991, 27:105-108.
3. Balster R.L., Bigelow G.E. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 2003, 70:S13-S40.
4. Bartoletti M., Gaiardi M., Gubellini G., Bacchi A., Babbini M. Long-term sensitization to the excitatory effects of morphine: a motility study in post-dependent rats. Neuropharmacology 1983, 22:1193-1196.
5. Biederman J., Pliszka S.R. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J Pediatr 2008, 152:394-399.
6. Carroll M.E., France C.P., Meisch R.A. Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J Pharmacol Exp Ther 1981, 217:241-247.
7. Carter L.P., Griffiths R.R. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 2009, 105:S14-S25.
8. Castells X., Casas M., Vidal X., Bosch R., Roncero C., Ramos-Quiroga J.A., Capellà D. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Addiction 2007, 102:1871-1887.
9. Cooper M.R., Bird H.M., Steinberg M. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann Pharmacother 2009, 43:721-725.
10. Cornish J.L., Kalivas P.W. Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis 2001, 20:43-54.
11. Cunningham C.S., Polston J.E., Jany J.R., Segert I.L., Miller D.K. Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine. Drug Alcohol Depend 2006, 84:211-222.
12. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205-211.
13. de Saint Hilaire Z., Orosco M., Rouch C., Blanc G., Nicolaidis S. Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. NeuroReport 2001, 12:3533-3537.
14. Deroche-Gamonet V., Darnaudéry M., Bruins-Slot L., Piat F., Le Moal M., Piazza P.V. Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology 2002, 161:387-395.
15. Desai R.I., Barber D.J., Terry P. Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine. Behav Pharmacol 1999, 10:647-656.
16. D'Mello G.D., Stolerman I.P. Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats. Br J Pharmacol 1977, 61:415-422.
17. Dopheide M.M., Morgan R.E., Rodvelt K.R., Schachtman T.R., Miller D.K. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants. Eur J Pharmacol 2007, 568:112-123.
18. Filip M., Papla I. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?. Pol J Pharmacol 2001, 53:577-585.
19. Fuxe K., Janson A.M., Rosén L., Finnman U.B., Tanganelli S., Morari M., Goldstein M., Agnati L.F. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp Brain Res 1992, 88:117-130.
20. Gold L.H., Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 1996, 126:286-292.
21. Hart C.L., Haney M., Vosburg S.K., Rubin E., Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008, 33:761-768.
22. Holtzman S.G. Drug discrimination studies. Drug Alcohol Depend 1985, 14:263-282.
23. Hsu C.W., Chen C.Y., Wang C.-S., Chiu T.H. Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75 DARPP-32 in mice. Psychopharmacology 2009, 204:313-325.
24. Huang D., Wilson M.C. Comparative discriminative stimulus properties of dl-cathinone, d-amphetamine, and cocaine in rats. Pharmacol Biochem Behav 1986, 24:205-210.
25. Järbe T.U. Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs. Neuropharmacology 1984, 23:899-907.
26. Jones C.N., Howard J.L., McBennett S.T. Stimulus properties of antidepressants in the rat. Psychopharmacology 1980, 67:111-118.
27. Kahbazi M., Ghoreishi A., Rahiminejad F., Mohammadi M.R., Kamalipour A., Akhondzadeh S. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res 2009, 10.1016/j.psychres.2008.06.024.
28. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 1990, 254:312-317.
29. Kohli S., Fisher S.G., Tra Y., Adams M.J., Mapstone M.E., Wesnes K.A., Roscoe J.A., Morrow G.R. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 2009, 115:2605-2616.
30. Lamb R.J., Griffiths R.R. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology 1990, 102:183-190.
31. Macenski M.J., Meisch R.A. Cocaine self-administration under conditions of restricted and unrestricted food access. Exp Clin Psychopharmacol 1999, 7:324-337.
32. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., Johnson R., Livni E., Spencer T.J., Bonab A.A., Miller G.M., Fischman A.J. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006, 319:561-569.
33. Mann N., Bitsios P. Modafinil treatment of amphetamine abuse in adult ADHD. J Psychopharmacol 2009, 23:468-471.
34. Meliska C.J., Landrum R.E., Landrum T.A. Tolerance and sensitization to chronic and subchronic oral caffeine: effects on wheelrunning in rats. Pharmacol Biochem Behav 1990, 35:477-479.
35. Mignot E., Nishino S., Guilleminault C., Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994, 17:436-437.
36. Minzenberg M.J., Carter C.S. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008, 33:1477-1502.
37. Myrick H., Malcolm R., Taylor B., LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann Clin Psychiatry 2004, 16:101-109.
38. National Institutes of Health Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, D.C.
39. Negus S.S., Gatch M.B., Mello N.K. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 1998, 18:325-338.
40. Nielsen J.A., Shannon N.J., Bero L., Moore K.E. Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacol Biochem Behav 1986, 24:795-799.
41. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 1992, 7:7-14.
42. Paterson N.E., Myers C., Markou A. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology 2000, 152:440-446.
43. Rabkin J.G., Gordon P.H., McElhiney M., Rabkin R., Chew S., Mitsumoto H. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve 2009, 39:297-303.
44. Reith M.E. Effect of repeated administration of various doses of cocaine and WIN 35, 065-2 on locomotor behavior of mice. Eur J Pharmacol 1986, 130:65-72.
45. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
46. Rush C.R., Kelly TH, Hays L.R., Baker R.W., Wooten A.F. Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol 2002, 13:105-115.
47. Rush C.R., Kelly T.H., Hays L.R., Wooten A.F. Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend 2002, 67:311-322.
48. Shoaib M., Stolerman I.P. MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br J Pharmacol 1992, 105:514-515.
49. Short P.H., Shuster L. Changes in brain norepinephrine associated with sensitization to d-amphetamine. Psychopharmacology 1976, 48:59-67.
50. Silverman P.B., Ho B.T. Discriminative response control by psychomotor stimulants. Psychopharmacol Commun 1976, 2:331-337.
51. Spealman R.D. Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 1993, 112:93-99.
52. Spealman R.D. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 1995, 275:53-62.
53. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., Rush C.R. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 2005, 182:186-193.
54. Suckow R.F., Smith T.M., Perumal A.S., Cooper T.B. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Drug Metab Dispos 1986, 14:692-697.
55. Tella S.R., Ladenheim B., Cadet J.L. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther 1997, 281:508-513.
56. Terry P., Katz J.L. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology 1997, 134:201-212.
57. Terry P., Witkin J.M., Katz J.L. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 1994, 270:1041-1048.
58. Thomas M.J., Kalivas P.W., Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 2008, 154:327-342.
59. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151:99-120.
60. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., Wang G.J., Jayne M., Hooker J.M., Wong C., Hubbard B., Carter P., Warner D., King P., Shea C., Xu Y., Muench L., Apelskog-Torres K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. J Am Med Assoc 2009, 301:1148-1154.
61. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21:1787-1794.
62. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998, 54:679-720.
63. Wood D.M., Emmett-Oglesby M.W. Characteristics of tolerance, recovery from tolerance and cross-tolerance for cocaine used as a discriminative stimulus. J Pharmacol Exp Ther 1986, 237:120-125.
64. Zolkowska D., Jain R., Rothman R.B., Partilla J.S., Roth B.L., Setola V., Prisinzano T.E., Baumann M.H. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther 2009, 329:738-746.